JPMorgan says this biotech stock can more than double following steep declines
- Posted on October 8, 2026
- By CNBC
- 1 Views
- 1 min read
In brief
Generating AI summary…
JPMorgan says this biotech stock can more than double following steep declines
The investment bank initiated coverage with an overweight rating.
